Press release
Strategic Manufacturing Award: Werum’s PAS-X is part of prize-winning IT program of Rottapharm | Madaus
Production in Dublin, Source Rottapharm | Madaus
Award honors Continuous Improvement Program of pharmaceutical manufacturer / with Werum’s PAS-X Manufacturing IT Business Platform to paperless factory
Lueneburg, Germany, 19 December 2012 – The pharmaceutical company Rottapharm | Madaus has won the 2012 Strategic Manufacturing Award in the category “Outstanding Achievement in Continuous Improvement” and the cross-competition “SMA e-F@ctory Hall of Fame” award for its Irish production plant in Dublin. The prizes pay tribute to the Continuous Improvement Program of Rottapharm | Madaus, in which the PAS-X Manufacturing IT Business Platform of Werum plays an important role.
Werum had rolled out PAS-X step by step at the Dublin plant since 2009. It began with the warehouse implementation, followed by the manufacturing and packaging areas. PAS-X integrates Enterprise Resource Planning (ERP) and several Distributed Control Systems (DCS).
“Our goal is to achieve a paperless factory. For this purpose, we automated the processes in the warehouse, in our manufacturing and packaging areas and reduced the number of manual entries,” said Áine Tobin, Project Manager, Rottapharm | Madaus Ltd. “With PAS-X we were able to eliminate over 720,000 wet signatures and to release batches in less than half the original time. On the other hand, the inventory accuracy has now increased to 99 percent.”
Werum’s PAS-X is a major building block within Rottapharm's Continuous Improvement Program with which the pharmaceutical manufacturer continually reduces non-value-added activities and lastingly expands its competitiveness.
About Rottapharm | Madaus Ltd.
Rottapharm | Madaus is a multinational pharmaceutical group based in Italy with its headquarters and research centre in Monza and possessing branches in over 85 countries. Rottapharm‘s long history of success began in 1961 with the creation of a small laboratory of independent research. From then on, the company has always invested in research, innovation, development and distribution on a global scale of new products mainly in the field of pharmaceuticals and, in the following years, also in the fields of parapharmaceuticals and neutraceuticals. www.rottapharm-madaus.com
About Werum Software & Systems AG
With over 40 years of software development experience, Werum Software & Systems AG is known worldwide for partnering with its global customers to create state-of-the-art software products and solutions. Werum is the internationally leading supplier of Manufacturing IT / Manufacturing Execution Systems for the pharmaceutical and biopharmaceutical industries. Its Manufacturing IT Business Platform PAS-X is used by 16 of the world’s top 30 pharmaceutical and biotech companies in more than 600 installations. Founded in 1969, the IT company employs about 470 people at its headquarters in Lueneburg, Germany, and at eight other locations in Germany, France, the United States, Japan, and Singapore. For more information take a look at our websites at www.werum.com and www.pas-x.com.
Dirk Ebbecke
DirectorCorporate Communications
Werum Software & Systems AG
Wulf-Werum-Strasse 3
21337 Lueneburg, Germany
Tel. +49 4131 8900-689
Fax +49 4131 8900-20
dirk.ebbecke@werum.com
For further information, visit Werum’s press center at www.press.werum.com.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strategic Manufacturing Award: Werum’s PAS-X is part of prize-winning IT program of Rottapharm | Madaus here
News-ID: 246950 • Views: …
More Releases from Werum Software & Systems AG
Research Made Easy
With their web-based data management system DSHIP the German-based company Werum Software & Systems supports maritime research on board of research vessels all over the world.
The Instagram profile of the current climate research expedition MOSAiC in the North Polar Sea shows straightaway: research work on the high seas may be really fascinating, but it also is extremely laborious, fragmented and highly complex. As they depend on the various environmental conditions…
Werum’s "PAS-X Reports & Labels" Content Packages significantly reduce MES imp …
Werum’s "PAS-X Reports & Labels" Content Packages significantly reduce MES implementation times
Best practice consulting services and “Out of the Box”-templates for GMP-compliant reports and labels
Lueneburg, Germany, 29 January 2014 – By providing "PAS-X Reports & Labels" Content Packages, Werum Software & Systems now offers an even broader range of pre-configured reports and labels along with the associated comprehensive consulting services to its customers.
These packages are based on best practices…
Werum accelerates MBR creation by providing "PAS-X MBR Design Elements" Content …
Werum accelerates MBR creation by providing "PAS-X MBR Design Elements" Content Packages
New "PAS-X MBR Design Elements" Content Packages based on industry best practice / process-specific and fast MBR creation for pharmaceutical production
Lueneburg, Germany, 28 November 2013 – In order for pharma and biotech customers to implement PAS-X MES projects even faster and more easily, Werum Software & Systems expands its PAS-X Content Packages offering further: New on the market are…
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP softw …
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP software
AWI puts new RV Mya II into service / Werum's data management system DSHIP ensures acquisition, archiving and evaluation of measurement data
Lueneburg, Germany, 23 October 2013 – The new RV Mya II, which has only recently been delivered to the German Alfred Wegener Institute, Helmholtz Center for Polar and Marine Research (AWI), has been equipped by Werum Software…
More Releases for Rottapharm
Cholecystokinin Receptor (CCK) Antagonist Market 2020 New Innovations in Medical …
Cholecystokinin Receptor (CCK) Antagonist -Pipeline Insight, 2020
The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Cholecystokinin Receptor (CCK) Antagonist Market on the basis of stating current situation of the industry in 2020.
This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of…
Diacerein Market potential growth, share, demand and analysis of key players - r …
This detailed market study covers diacerein market growth potentials which can assist the stake holders to understand key trends and prospects in diacerein market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The analysis also…
Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth, Challeng …
"The new report has been added by qyresearch.com to provide detailed insight into the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market. The study will help to get a better understanding about the Gastroesophageal Reflux Disease (GERD) Drugs and Devices industry competitors, a channel for the distribution, Gastroesophageal Reflux Disease (GERD) Drugs and Devices growth potential, potentially disruptive trends, Gastroesophageal Reflux Disease (GERD) Drugs and Devices industry product innovations,…
Diacerein Market Research and Projections for 2020-2026| TRB Pharma, Novartis, T …
Complete study of the global Diacerein market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Diacerein industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate…
Best Statistical Report of Human Papillomavirus Protein E6 Market Trend Expected …
Up Market Research offers a latest published report on “Global Human Papillomavirus Protein E6 Market Research Report 2019” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 104 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Request Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/63749
Human Papillomavirus Protein E6 Market research report…
Obsessive-Compulsive Disorder Treatment Global Outlook 2018: Novartis AG, Omeros …
Qyresearchreports include new market research report “2018-2025 Obsessive-Compulsive Disorder Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports.
The global market for Obsessive-Compulsive Disorder Treatment has been witnessing a continued alteration in the pattern of the demand for Obsessive-Compulsive Disorder Treatment. This research report attempts to understand the frequent changes in the consumer behavior and their impact…
